scholarly journals One Center's Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation

2016 ◽  
Vol 10 ◽  
pp. CMPed.S38336 ◽  
Author(s):  
Corinne A. Muirhead ◽  
Julian N. Sanford ◽  
Benjamin G. Mccullar ◽  
Dawn Nolt ◽  
Kelvin D. Macdonald

Cystic fibrosis (CF) is a chronic disorder characterized by acute pulmonary exacerbations that comprise increased cough, chest congestion, increased mucus production, shortness of breath, weight loss, and fatigue. Typically, severe episodes are treated in the inpatient setting and include intravenous antimicrobials, airway clearance therapy, and nutritional support. Children with less-severe findings can often be managed as outpatients with oral antimicrobials and increased airway clearance therapy at home without visiting the specialty CF center to begin treatment. Selection of specific antimicrobial agents is dependent on pathogens found in surveillance culture, activity of an agent in patients with CF, and the unique physiology of these patients. In this pediatric review, we present our practice for defining acute pulmonary exacerbation, deciding treatment location, initiating treatment either in-person or remotely, determining the frequency of airway clearance, selecting antimicrobial therapy, recommending timing for follow-up visit, and recognizing and managing treatment failures.

2010 ◽  
Vol 35 (9) ◽  
pp. 1028-1037 ◽  
Author(s):  
A. C. Modi ◽  
A. E. Cassedy ◽  
A. L. Quittner ◽  
F. Accurso ◽  
M. Sontag ◽  
...  

2019 ◽  
Vol 64 (7) ◽  
pp. 778-785 ◽  
Author(s):  
Allen C Sherman ◽  
Stephanie Simonton-Atchley ◽  
Dianne Campbell ◽  
Raghu M Reddy ◽  
Catherine E O'Brien ◽  
...  

2018 ◽  
Vol 64 (2) ◽  
pp. 176-181 ◽  
Author(s):  
Gabriela R Oates ◽  
Irena Stepanikova ◽  
Steven M Rowe ◽  
Stephanie Gamble ◽  
Hector H Gutierrez ◽  
...  

2020 ◽  
Vol 4 (1) ◽  
pp. e000792
Author(s):  
Niamh Kiernan ◽  
Barry Johnstone ◽  
Peter Anderson ◽  
Ruth Stewart

This study was a clinical review of infant positive expiratory pressure (PEP) therapy in young children with cystic fibrosis (CF). The aim of this study was to determine whether pressures of 10–20 cm H2O PEP therapy (recommended by the CF trust) are being achieved with routine airway clearance therapy. This took place at the Royal Hospital for Children, Glasgow a specialist UK CF centre. Values were obtained from 21 young children. Pressures above 10 cm H2O during tidal volume breathing were not achieved within our cohort. Further investigation is required to determine efficacy of lower pressures in PEP therapy with young children.


Sign in / Sign up

Export Citation Format

Share Document